Skylight Health Reports Q3 Results Achieving Consecutive Quarter and YTD Positive Adjusted EBITDA

    NEXT STORY
    Junshi Biosciences Announces Acceptance by NMPA of its IND Application for JS006
    PREV STORY
    Phathom Pharmaceuticals Announces Completion of Patient Enrollment in Pivotal Phase 3 Erosive Esophagitis Trial
    Subscribe to PM360
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    The Finnish Competition and Consumer Authority has given the final approval for the transaction between Terveystalo and Attendo which is intended to be completed on 28 December 2018

    Terveystalo Plc Stock exchange release 14 December 2018 at 13:00 EET Terveystalo signed an ...

    author_avatar
    NASDAQ Market News

    ASTRAZENECA PLC ANNOUNCES MEDIMMUNE OUT-LICENSES POTENTIAL MEDICINE FOR INFLAMMATORY DISEASES TO ALLERGAN

    This announcement contains inside information 03 October 2016 07:00 AstraZeneca today announced that MedImmune, ...

    author_avatar
    NASDAQ Market News

    $4.95 Bn Microbiology Testing/Clinical Microbiology Market – Global Forecast to 2023

    Dublin, Sept. 20, 2018 (GLOBE NEWSWIRE) -- The "Microbiology Testing/Clinical Microbiology Market by Application ...

    author_avatar
    NASDAQ Market News